Search results (17)
« Back to NewsOxford and partners lead on two new MRC Centres to create cutting-edge gene therapies
11 December 2024
Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.
Athena Swan Gold award
9 September 2024
The Department of Paediatrics has been awarded the Athena Swan Gold award for its commitment to advancing gender equality in higher education. Established in 2005 to encourage and recognise commitment to advancing the careers of women in science, technology, engineering, maths and medicine (STEMM) employment, the Charter is now used across the globe to address gender equality and barriers to progression that affect women.
New research identifies autoimmunity against a key anti-inflammatory regulator in inflammatory bowel disease
4 August 2024
- Clinical Trials
- Department
- Gastroenterology
- Immunology
- Publication
- Research
- Research Methods
- University
A ground-breaking study, published by the New England Journal of Medicine, has identified a new disease-inducing mechanism for inflammatory bowel disease (IBD) in which the immune system attacks its own regulatory function.
Research shows early life immunity increases HIV cure/remission in male infants
10 June 2024
New research published by scientists at the University of Oxford, the University of KwaZulu-Natal and the Africa Health Research Institute in South Africa, and the Ragon Institute of Mass General, MIT and Harvard, USA, shows that male infants are more likely to achieve HIV cure/remission than females.
How the Information Security Office and the National Cyber Security Centre keeps Oxford's research secure post-pandemic
2 May 2024
Oxford University's Information Security Office (InfoSec) invited the NCSC to Oxford to thank them for the work they did that kept Oxford’s vaccine research secure.
Oxford University professors on the record with their contribution to the fight against cancer for this World Cancer Day
4 February 2024
This World Cancer Day, four Principal Investigators from the University of Oxford, including Andi Roy, Professor of Paediatric Haematology at the Department of Paediatrics, talk candidly about their work and how they’re helping the fight against cancer.
Oxford University Professors to lecture on new course in 'Translational Science' at three Brazilian institutions
1 February 2024
The Department of Paediatrics at the University of Oxford, has entered into an agreement with three Brazilian Universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024.
FCDO Minister meets with vaccine researchers
25 January 2024
Researchers from the Department of Paediatrics today welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
DoP professor named in New Year's Honours list
4 January 2024
Matthew Snape, Professor of Paediatrics and Vaccinology at the Oxford Vaccine Group (OVG) before moving to Moderna in August 2022, has been appointed Member of the Most Excellent Order of the British Empire (MBE) for services to Public Health, particularly during COVID-19 while working at the OVG.
The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
3 October 2023
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.
Future of Chair in Global Health secured with £5 million gift
20 September 2023
The University of Oxford’s commitment to tackling major global health challenges has been strengthened following the endowment of a chair in global health and clinical development. The new permanent post was made possible by a £5 million donation from Brazilian healthcare organisation SAIL for Health.
Anindita Roy appointed Professor of Paediatric Haematology
13 September 2023
The Department of Paediatrics at the University of Oxford is delighted to announce that Anindita Roy has been named Professor of Paediatric Haematology at the University of Oxford.
University of Oxford partners with CEPI to counter the threat of future pandemics
31 August 2023
The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
Director of Global Operations at OVG recognised in the King’s Birthday Honours 2023
22 June 2023
Dr Parvinder Aley, Director of Global Operations at the Oxford Vaccine Group, has been recognised and celebrated in the 2023 King’s Birthday Honours list. Dr Aley has been appointed an Officer of the Order of the British Empire (OBE) for services to vaccination during the COVID-19 pandemic.
Sharing the benefits
20 March 2020
At the beginning of the year our family leave policies were updated. Employees can now take up most of our family leave schemes from the first day of employment, meaning that more parents can now enjoy the benefits of our generous provisions. Hayriye Cagnan from the Nuffield Department of Clinical Neurosciences, and husband Eugene Duff from the Department of Paediatrics, discuss their experience of shared parental leave following baby Ida’s arrival ten months ago.
Oxford-Harrington Rare Disease Centre to research rare diseases therapies
28 February 2019
The University of Oxford and Harrington Discovery Institute at University Hospitals have announced a new affiliation to advance therapies for rare diseases. The joint program combines capabilities to improve treatment options globally for patients with rare diseases.
Neonatologist Dominic Wilkinson has been made Professor
18 July 2016
The title of full Professor has been conferred upon Dominic Wilkinson